Skip to main content
Dryad

Fatal and non-fatal events within 14 days after early, intensive mobilization post stroke

Data files

May 07, 2021 version files 2.71 MB

Abstract

Objective: We examined fatal and non-fatal Serious Adverse Events (SAEs) at 14 days within AVERT.

Method: A prospective, parallel group, assessor blinded, randomized international clinical trial comparing very early intensive mobilization training (VEM) with usual care (UC); with follow up to 3 months. Included: Patients with ischaemic and haemorrhagic stroke within 24 hours of onset and physiological parameters within set limits. Treatment with thrombolytics allowed. Excluded: Patients with severe premorbid disability and/or comorbidities. Interventions continued for 14 days or hospital discharge if less. The primary early safety outcome was fatal SAEs within 14 days. Secondary outcomes were non-fatal SAEs classified as neurological, immobility-related, and other. Mortality influences were assessed using binary logistic regression adjusted for baseline stroke severity (NIHSS) and age.

Results: 2104 participants were randomized to VEM (n=1054) or UC (n=1050) with a median age of 72 years (IQR 63-80) and NIHSS 7 (IQR 4-12). By 14 days, 48 had died in VEM, 32 in UC, adjusted Odds Ratio of 1.76 (95% CI 1.06-2.92, P=.029). Stroke progression was more common in VEM. Exploratory subgroup analyses showed higher odds of death in those; >80 years, and with intracerebral haemorrhage, but there was no significant treatment by subgroup interaction. No difference in non-fatal SAEs found.

Conclusions: While the overall case fatality at 14 days post-stroke was only 3.8%, age and severity adjusted mortality was increased with high dose, intensive training compared to usual care. Stroke progression was more common in VEM. Data suggests that older people and those with intracerebral haemorrhage are at higher risk.

Classification of Evidence: This study provides Class I evidence that very early mobilization increases mortality at 14 days post stroke.